PT76528A - Nouveaux derives d'arene et d'heteroarenecarboxamides et leur utilisation comme medicaments - Google Patents
Nouveaux derives d'arene et d'heteroarenecarboxamides et leur utilisation comme medicamentsInfo
- Publication number
- PT76528A PT76528A PT76528A PT7652883A PT76528A PT 76528 A PT76528 A PT 76528A PT 76528 A PT76528 A PT 76528A PT 7652883 A PT7652883 A PT 7652883A PT 76528 A PT76528 A PT 76528A
- Authority
- PT
- Portugal
- Prior art keywords
- heteroarenecarboxamide
- medicaments
- derivatives
- arene
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8207217A FR2525595A1 (fr) | 1982-04-27 | 1982-04-27 | Nouveaux derives d'arene et d'heteroarenecarboxamides et leur utilisation comme medicaments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT76528A true PT76528A (fr) | 1983-05-01 |
| PT76528B PT76528B (fr) | 1985-12-09 |
Family
ID=9273433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT76528A PT76528B (fr) | 1982-04-27 | 1983-04-08 | Nouveaux derives d'arene et d'heteroarenecarboxamides et leur utilisation comme medicaments |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4499094A (pt) |
| EP (1) | EP0094271B1 (pt) |
| JP (1) | JPS58201756A (pt) |
| AU (1) | AU555417B2 (pt) |
| CA (1) | CA1207324A (pt) |
| DE (1) | DE3365086D1 (pt) |
| DK (1) | DK184783A (pt) |
| ES (1) | ES521864A0 (pt) |
| FR (1) | FR2525595A1 (pt) |
| GR (1) | GR77909B (pt) |
| HU (1) | HU189271B (pt) |
| IL (1) | IL68326A0 (pt) |
| MA (1) | MA19777A1 (pt) |
| NO (1) | NO831466L (pt) |
| PT (1) | PT76528B (pt) |
| ZA (1) | ZA832925B (pt) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2538388B1 (fr) * | 1982-12-24 | 1985-06-21 | Pharmuka Lab | Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments |
| US4649146A (en) * | 1983-01-31 | 1987-03-10 | Fujisawa Pharmaceutical Co., Ltd. | Thiazole derivatives and pharmaceutical composition comprising the same |
| FR2582514B1 (fr) * | 1985-05-30 | 1988-02-19 | Rhone Poulenc Sante | Medicaments a base d'amides, nouveaux amides et leur preparation |
| HU196758B (en) * | 1986-05-21 | 1989-01-30 | Gyogyszerkutato Intezet | Process for production of 3-hidroxi-methil-quinolines and medical compositions containing them |
| DE3752373T2 (de) * | 1986-10-13 | 2004-03-25 | Asahi Kasei Kogyo K.K. | Pyridin-derivate |
| EP0346841A3 (de) * | 1988-06-16 | 1991-01-09 | Ciba-Geigy Ag | 1-Aryl-naphthoesäureamide und diese enthaltende mikrobizide Mittel |
| US5219864A (en) * | 1991-03-12 | 1993-06-15 | Kyowa Hakko Kogyo Co., Ltd. | Thienopyridine derivatives |
| US5550124A (en) * | 1991-12-10 | 1996-08-27 | University Of Southern California | Use of peripheral-type benzodiazpine sites for treatment of CNS trauma or disease |
| IL117659A (en) * | 1995-04-13 | 2000-12-06 | Dainippon Pharmaceutical Co | Substituted 2-phenyl pyrimidino amino acetamide derivative process for preparing the same and a pharmaceutical composition containing same |
| WO1998014213A1 (fr) | 1996-10-01 | 1998-04-09 | Daiichi Pharmaceutical Co., Ltd. | Stabilisateur de la membrane mitochondriale |
| WO1998049155A1 (en) * | 1997-04-25 | 1998-11-05 | Takeda Chemical Industries, Ltd. | Cell differentiation inducing amide derivatives, their production and use |
| WO1998049900A1 (en) * | 1997-05-07 | 1998-11-12 | Emory University | Haloisoquinoline carboxamide |
| ZA9810490B (en) | 1997-12-03 | 1999-05-20 | Dainippon Pharmaceutical Co | 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor |
| FR2778564B1 (fr) * | 1998-05-13 | 2001-07-13 | Sanofi Sa | Utilisation de composes reduisant l'apoptose |
| WO1999058117A1 (fr) * | 1998-05-13 | 1999-11-18 | Sanofi-Synthelabo | Utilisation de composes reduisant l'apoptose |
| ES2246588T3 (es) * | 1998-12-18 | 2006-02-16 | Scios Inc. | Tratamiento de enfermedades que implican formacion de quistes. |
| GB0516723D0 (en) * | 2005-08-15 | 2005-09-21 | Novartis Ag | Organic compounds |
| US8541428B2 (en) * | 2006-08-22 | 2013-09-24 | Technion Research And Development Foundation Ltd. | Heterocyclic derivatives, pharmaceutical compositions and methods of use thereof |
| WO2008063625A2 (en) * | 2006-11-20 | 2008-05-29 | Adolor Corporation | Pyridine compounds and methods of their use |
| JP5441060B2 (ja) * | 2007-10-31 | 2014-03-12 | 独立行政法人理化学研究所 | 創薬のためのｐｅｔスクリーニング用分子プローブを製造するためのキット |
| GB0907284D0 (en) | 2009-04-28 | 2009-06-10 | Queen Mary & Westfield College | Compounds for inducing cellular apoptosis |
| WO2014164678A1 (en) * | 2013-03-12 | 2014-10-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Translocator protein imaging agents; methods of manufacture, and methods of use thereof |
| JP6498695B2 (ja) | 2014-04-23 | 2019-04-10 | テクニオン・リサーチ・アンド・ディベロップメント・ファウンデーション・リミテッド | キナゾリン骨格系の化合物、医薬組成物およびその使用方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1069296A (en) * | 1912-07-31 | 1913-08-05 | Hoechst Ag | Derivatives of phenylcinchoninic acid. |
| BE764299A (en) * | 1971-03-12 | 1971-08-16 | Malesci Sas | Antifibrillatory ethylenediamines or imida- - zolines |
| FR2417512A1 (fr) * | 1978-02-17 | 1979-09-14 | Parcor | Thieno (3,2-c) et thieno (2,3-c) pyridines, leur procede de preparation et leur application en therapeutique |
| FR2485014A1 (fr) * | 1980-06-20 | 1981-12-24 | Pharmindustrie | Nouveaux derives de (quinolyl-2, -3 ou -4)-1 (piperidyl ou pyrrolidinyl-2 ou -3)-2 ou -3 ethanone ou propanone, procedes pour leur preparation, et leur utilisation comme medicaments |
-
1982
- 1982-04-27 FR FR8207217A patent/FR2525595A1/fr active Granted
-
1983
- 1983-03-30 GR GR70936A patent/GR77909B/el unknown
- 1983-04-05 US US06/482,082 patent/US4499094A/en not_active Expired - Fee Related
- 1983-04-07 IL IL68326A patent/IL68326A0/xx unknown
- 1983-04-08 PT PT76528A patent/PT76528B/pt unknown
- 1983-04-14 CA CA000425918A patent/CA1207324A/fr not_active Expired
- 1983-04-15 EP EP83400749A patent/EP0094271B1/fr not_active Expired
- 1983-04-15 DE DE8383400749T patent/DE3365086D1/de not_active Expired
- 1983-04-25 MA MA19997A patent/MA19777A1/fr unknown
- 1983-04-26 ZA ZA832925A patent/ZA832925B/xx unknown
- 1983-04-26 JP JP58073653A patent/JPS58201756A/ja active Granted
- 1983-04-26 DK DK184783A patent/DK184783A/da not_active Application Discontinuation
- 1983-04-26 HU HU831431A patent/HU189271B/hu unknown
- 1983-04-26 NO NO831466A patent/NO831466L/no unknown
- 1983-04-26 ES ES521864A patent/ES521864A0/es active Granted
- 1983-04-27 AU AU14002/83A patent/AU555417B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ES8406419A1 (es) | 1984-08-01 |
| AU1400283A (en) | 1983-11-03 |
| FR2525595B1 (pt) | 1985-03-22 |
| JPH0324467B2 (pt) | 1991-04-03 |
| CA1207324A (fr) | 1986-07-08 |
| EP0094271A2 (fr) | 1983-11-16 |
| EP0094271A3 (en) | 1984-07-04 |
| US4499094A (en) | 1985-02-12 |
| MA19777A1 (fr) | 1983-12-31 |
| DK184783D0 (da) | 1983-04-26 |
| PT76528B (fr) | 1985-12-09 |
| HU189271B (en) | 1986-06-30 |
| GR77909B (pt) | 1984-09-25 |
| NO831466L (no) | 1983-10-28 |
| ES521864A0 (es) | 1984-08-01 |
| JPS58201756A (ja) | 1983-11-24 |
| IL68326A0 (en) | 1983-07-31 |
| ZA832925B (en) | 1984-01-25 |
| EP0094271B1 (fr) | 1986-08-06 |
| AU555417B2 (en) | 1986-09-25 |
| DE3365086D1 (en) | 1986-09-11 |
| DK184783A (da) | 1983-10-28 |
| FR2525595A1 (fr) | 1983-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT76528B (fr) | Nouveaux derives d'arene et d'heteroarenecarboxamides et leur utilisation comme medicaments | |
| BE882937A (fr) | Esters d'acyl carnitines, leur preparation et leur utilisation | |
| FR2551064B1 (fr) | Nouveaux esters et amides aromatiques, leur preparation et leur utilisation comme medicaments | |
| BE880905A (fr) | Compositions influencant le systeme nerveux central et leur methode d'utilisation | |
| FR2542000B1 (fr) | Nouveaux derives de l'ethanol, leur preparation et leur utilisation comme fongicides | |
| FR2535321B1 (fr) | Nouveaux derives de l'ethanol, leur preparation et leur utilisation comme fongicides | |
| BE858802A (fr) | Compositions d'isocyanate et leur preparation | |
| MA19845A1 (fr) | Nouvelles piperidinamines et leur preparation | |
| TR21696A (tr) | Yeni substituee n-fenil-n'-benzoil uereler ve bunlarin enssektisidler ve akarisidler olarak kullanimi | |
| BE896993A (fr) | FACTEURS 1,2,3,4 et 5 DE TEICHOMYCINE A2, LEUR PREPARATION ET LEUR UTILISATION | |
| FR2511003B1 (fr) | Alacaloides ergopeptidiques, leur preparation et leur utilisation comme medicaments | |
| FR2531962B1 (fr) | Nouveaux derives de la desoxyuridine, leur preparation et leur utilisation comme medicaments | |
| FR2551438B1 (fr) | Nouveaux derives de l'ethanol, leur preparation et leur utilisation comme fongicides | |
| FR2540112B1 (fr) | Nouveaux derives de la benzo(g)quinoleine, leur preparation et leur utilisation comme medicaments | |
| BE896590A (fr) | Nouveaux azepino-indoles leur preparation et leur utilisation comme medicaments | |
| FR2527608B1 (fr) | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments | |
| FR2549058B1 (fr) | Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments | |
| FR2528431B1 (fr) | Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments | |
| FR2527206B1 (fr) | Nouveaux derives de la 2(1h)-pyridinone, leur preparation et leur utilisation comme medicaments | |
| PT73190B (fr) | Nouveaux derives de l'indene procedes pour leur preparation et leur utilisation comme medicaments | |
| FR2530634B1 (fr) | Derives du carbapeneme, leur preparation et leur utilisation comme medicaments | |
| FR2536072B1 (fr) | Nouveaux derives de la quinazoline, leur preparation et leur utilisation comme medicaments | |
| FR2520741B1 (fr) | Nouveaux derives du benzothiophene, leur preparation et leur utilisation comme medicaments | |
| FR2519982B1 (fr) | Nouveaux derives de l'indoline, leur preparation et leur utilisation comme medicaments | |
| BE891585A (fr) | 5 alpha-androstane-17 beta-carboxylates et 5 beta-androstane-17 beta-carboxylates, leur preparation et leur utilisation |